| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/13/1997 | WO1997004775A1 Quinolones and their therapeutic use |
| 02/13/1997 | WO1997004768A1 Non-ionic surfactant vesicles as therapeutic agent |
| 02/13/1997 | WO1996040627A3 Thiocationic lipids, pharmaceutical compositions and methods of use thereof |
| 02/13/1997 | WO1996035774A3 Angiostatin fragments and aggregate angiostatin and methods of use |
| 02/13/1997 | CA2228298A1 Non-ionic surfactant vesicles as therapeutic agent |
| 02/13/1997 | CA2227364A1 Cyclic peptide anti-fungal agents |
| 02/13/1997 | CA2227327A1 Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease |
| 02/13/1997 | CA2225555A1 Quinolones and their therapeutic use |
| 02/13/1997 | CA2225552A1 Quinolones and their therapeutic use |
| 02/13/1997 | CA2201478A1 New carboxamides with antifungal activity |
| 02/12/1997 | EP0757990A1 7-(1-Pyrrolidoinyl)-3-quinolone and naphthyridone carboxylic acid derivatives, method for their preparation and for substituted mono- and bicyclic pyrrolidine intermediates, and their antibacterial and feed additive compositions |
| 02/12/1997 | EP0757722A1 HERPES VIRUS TRANSFORMED TO EXPRESS gD $i(IN VITRO) |
| 02/12/1997 | EP0757719A1 $g(a)-1-ANTICHYMOTRYPSIN ANALOGUES HAVING CHYMASE INHIBITING ACTIVITY |
| 02/12/1997 | EP0757717A1 Papillomavirus vaccines |
| 02/12/1997 | EP0757697A1 Use of agents which block intercellular adhesion molecule/receptor interaction in the treatment of respiratory viral infection |
| 02/12/1997 | EP0757692A1 Methanol derivatives for treatment of retroviral infections especially hiv infections |
| 02/12/1997 | EP0757690A1 Electron-deficient porphyrins and processes and intermediates for preparing same |
| 02/12/1997 | EP0757675A1 Novel quinolone 5-(n-heterosubstituted amino) antimicrobials |
| 02/12/1997 | EP0757669A1 O-acyl-4-phenyl-cyclohexanols, their salts, medicaments containing such compounds and their use, as well as a method of preparing them |
| 02/12/1997 | EP0757556A1 $i(BORRELIA BURGDORFERI) BACTERIN |
| 02/12/1997 | EP0546179B1 4-o-(aminoglycosyl)- or 4,6-di-o-(aminoglycosyl)-2,5-dideoxy-5,5-difluorostreptamine derivative and production thereof |
| 02/12/1997 | CN1142854A C5a receptor antagonists having substantially no agonist activity |
| 02/12/1997 | CN1142830A Macrocyclic difluorostatone derivatives useful as antiviral agents |
| 02/12/1997 | CN1142828A Tetrahydrofuran antifungals |
| 02/12/1997 | CN1142827A HIV protease inhibitors |
| 02/12/1997 | CN1142820A Crystalline N-acetyl neuraminic acid derivatives and process for their preparation |
| 02/12/1997 | CN1142774A Vibrio cholerae 01(CVD111) and Non-01(CVD112 and CVD112RM) serogroup vaccine strains and methods of making same |
| 02/12/1997 | CN1142773A Probiotic for control of salmonella |
| 02/12/1997 | CN1142769A Pharmaceuticals |
| 02/12/1997 | CN1142499A Tricyclic 5,6-dihydro-9H-pyrazolo|3,4-c¨-1,2,4,-triaolo (4,3-alpha¨ pyridines |
| 02/11/1997 | US5602275 May be used to accelerate recovery from neutropenia accompanying radio- or chemotherapy, bone marrow transplantation or infections |
| 02/11/1997 | US5602254 Method for making quinoline carboxylic acids or naphthyridine carboxylic acids in free base form |
| 02/11/1997 | US5602250 6-(substituted methylene)penems and intermediates |
| 02/11/1997 | US5602229 Pentapeptide antibiotics |
| 02/11/1997 | US5602166 Administering an azaspirane derivatives |
| 02/11/1997 | US5602146 Antiviral agent |
| 02/11/1997 | US5602118 A 2-((2-substituted alkyl)fur-3-yl)-thio-),3-carboxy-2-carbopenem derivatives; effective against beta-lactam antibiotic-resistant bacteria |
| 02/11/1997 | US5602117 Cephalosporin compounds |
| 02/11/1997 | US5602022 Production of infectious bursal disease virus in mammalian cell line |
| 02/11/1997 | US5601989 Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy |
| 02/11/1997 | US5601973 Polypeptides for diagnostic identifying specific antibodies |
| 02/11/1997 | US5601848 Administering bismuth compound |
| 02/11/1997 | US5601831 Vaccines for nontypable Haemophilus influenzae |
| 02/11/1997 | US5601827 Replacing or deleting certain codons of naturally-occuring diphtheria toxin |
| 02/11/1997 | US5601825 Therapeutic conjugates of toxins and drugs |
| 02/11/1997 | US5601816 Infectious bovine rhinotracheitis virus insertion mutants, vaccines containing same, and methods for the production of same |
| 02/06/1997 | WO1997004118A1 Cd4 gene regulatory sequences specifically expressed in mature t cells |
| 02/06/1997 | WO1997004109A1 α-β C4BP-TYPE RECOMBINANT HETEROMULTIMERIC PROTEINS |
| 02/06/1997 | WO1997004105A1 Dna polymerase of gamma herpes viruses associated with kaposi's sarcoma and retroperitoneal fibromatosis |
| 02/06/1997 | WO1997004008A1 Anti-fungal peptides |
| 02/06/1997 | WO1997004005A2 Cyclosporin derivatives with anti-hiv effect |
| 02/06/1997 | WO1997004000A1 Hepadnavirus receptor |
| 02/06/1997 | WO1997003998A1 Modulators of the function of fas receptors and other proteins |
| 02/06/1997 | WO1997003957A1 Bis-(2-haloethyl)aminophenyl substituted distamycin derivatives as antitumor and antiviral agents |
| 02/06/1997 | WO1997003944A1 Aliphatic tricarboxylic acid compounds and their production process |
| 02/06/1997 | WO1997003696A1 COMPOSITIONS AND METHODS FOR CATALYZING HYDROLYSIS OF HIV gp120 |
| 02/06/1997 | WO1997003695A1 Methods for detecting, identifying, isolating, and selectively labelling and targeting th1 lymphocytes by means of the lag-3 protein |
| 02/06/1997 | WO1997003693A1 Type ii phospholipase a2 and its use in killing gram-positive bacteria |
| 02/06/1997 | WO1997003686A1 Tnf receptor and steroid hormone in a combined therapy |
| 02/06/1997 | WO1996040770A3 Anti-fungal d-amino acid histatin-based peptides |
| 02/06/1997 | WO1996037210A3 Pharmaceutical compositions, based on etheric oils obtained from plants for use in the human and veterinary medical field |
| 02/06/1997 | WO1996036324A3 Use of a pharmaceutically acceptable oxalate derivative in the manufacture of a medicament for the treatment of skin conditions |
| 02/06/1997 | CA2227441A1 Hepadvavirus receptor |
| 02/06/1997 | CA2227334A1 Methods for detecting, identifying, isolating, and selectively labelling and targeting th1 lymphocytes by means of the lag-3 protein |
| 02/06/1997 | CA2227292A1 Anti-fungal peptides |
| 02/06/1997 | CA2227035A1 Cd4 gene regulatory sequences specifically expressed in mature t cells |
| 02/06/1997 | CA2227030A1 .alpha.-.beta. c4bp-type recombinant heteromultimeric proteins |
| 02/06/1997 | CA2226872A1 Dna polymerase of gamma herpes viruses associated with kaposi's sarcoma and retroperitoneal fibromatosis |
| 02/06/1997 | CA2223914A1 Compositions and methods for catalyzing hydrolysis of hiv gp120 |
| 02/06/1997 | CA2199635A1 Bis-(2-haloethyl)aminophenyl substituted distamycin derivatives as antitumor and antiviral agents |
| 02/05/1997 | EP0757058A1 Cyclic peptide anti-fungal agents |
| 02/05/1997 | EP0757055A2 Glycosides, sugar-free degradation products and derivatives of the same |
| 02/05/1997 | EP0757050A1 Antibacterial penem esters derivatives |
| 02/05/1997 | EP0756630A1 Recombinant pgp3, methods of preparation and use in diagnosis and therapy |
| 02/05/1997 | EP0756603A1 Multirepresentation of a peptide analogue of the dppiv substrate, especially of the kpr type, to inhibit the entry of hiv in cells |
| 02/05/1997 | EP0756598A1 Substituted 5,6-dihydro-5-oxo-1,4-dithiino-(2,3-d)-pyridazine-2,3-dicarbonitriles, compositions containing them and their use as antimicrobials |
| 02/05/1997 | EP0756595A1 Substituted 1,3-oxathiolanes with antiviral properties |
| 02/05/1997 | EP0666850B1 1,2,3,5,6,7,8,8a-OCTAHYDRO-5,5,8a-TRIMETHYL-(8aBETA)-6-ISOQUINOLINEAMINE DERIVATIVES, PREPARATION METHOD THEREFOR AND THERAPEUTICAL USE THEREOF |
| 02/05/1997 | EP0652895A4 Compounds which inhibit hiv replication. |
| 02/05/1997 | CN1142231A Abundant extracellular products and methods for production and use of same |
| 02/05/1997 | CN1142230A Antibiotic stalobacins |
| 02/05/1997 | CN1142222A Diesters of carbonic acid endowed with antiviral and anti-inflammatory activity |
| 02/05/1997 | CN1142188A 人生长激素 Human Growth Hormone |
| 02/05/1997 | CN1141922A Cephalosporin derivative |
| 02/05/1997 | CN1141791A Ointment for treatment of bone tuberculosis |
| 02/05/1997 | CN1033974C Process for preparing erythromycin derivatives |
| 02/05/1997 | CN1033971C 9-|(substituted glycyl) amido¨-6-demethyl-6-deoxytetracyclines |
| 02/04/1997 | US5599984 Guanylhydrazones and their use to treat inflammatory conditions |
| 02/04/1997 | US5599924 Electron-deficient porphyrins and processes and intermediates for preparing same |
| 02/04/1997 | US5599839 Antiviral composition |
| 02/04/1997 | US5599796 Treatment of urogenital cancer with boron neutron capture therapy |
| 02/04/1997 | US5599791 Bactericide active against gramnegative and grampositive bacteria |
| 02/04/1997 | US5599693 Culture product |
| 02/04/1997 | US5599691 Herpes simplex virus as a vector |
| 02/04/1997 | US5599557 Stable hydrated cephalosporin dry powder for oral suspension formulation |
| 02/04/1997 | US5599545 Mycobacterium as adjuvant for antigens |
| 02/04/1997 | US5599537 Salmonella virulence genes |
| 02/04/1997 | CA2050255C 1-methylcarbapenem derivatives and process for preparation thereof |
| 02/04/1997 | CA2014202C Dichloro-substituted imidazole derivatives as antifungal agents |
| 02/04/1997 | CA2006703C Antibacterial anti-plaque oral composition |